Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-040100

Chief Scientific Officer sold 11,685 shares at an average $37.32 ($436,065)

  • Chief Scientific Officer acquired 11,685 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-06-09 Option exercise +3,895 $6.32 $24,616 73,255 D
ROBINS HARLAN S Chief Scientific Officer 2021-06-09 Sale −3,395 $35.91 $121,914 69,860 D
ROBINS HARLAN S Chief Scientific Officer 2021-06-09 Sale −500 $36.50 $18,250 69,360 D
ROBINS HARLAN S Chief Scientific Officer 2021-06-10 Option exercise +3,895 $6.32 $24,616 73,255 D
ROBINS HARLAN S Chief Scientific Officer 2021-06-10 Sale −1,100 $36.77 $40,447 72,155 D
ROBINS HARLAN S Chief Scientific Officer 2021-06-10 Sale −2,795 $37.87 $105,847 69,360 D
ROBINS HARLAN S Chief Scientific Officer 2021-06-11 Option exercise +3,895 $6.32 $24,616 73,255 D
ROBINS HARLAN S Chief Scientific Officer 2021-06-11 Sale −3,895 $38.41 $149,607 69,360 D
Derivatives
ROBINS HARLAN S Chief Scientific Officer 2021-06-09 Option exercise · Stock Option (Right to Buy) −3,895 124,640 D
ROBINS HARLAN S Chief Scientific Officer 2021-06-10 Option exercise · Stock Option (Right to Buy) −3,895 120,745 D
ROBINS HARLAN S Chief Scientific Officer 2021-06-11 Option exercise · Stock Option (Right to Buy) −3,895 116,850 D
Open-market sales · 11,685 sh · avg $37.32 · $436,065
Loading xslF345X03/doc4.xml…